Experimental vaccines against measles in a world of changing epidemiology.

@article{Ptz2003ExperimentalVA,
  title={Experimental vaccines against measles in a world of changing epidemiology.},
  author={Mike M P{\"u}tz and Fabienne B Bouche and Rik L de Swart and Claude P. Muller},
  journal={International journal for parasitology},
  year={2003},
  volume={33 5-6},
  pages={525-45}
}
Vaccination with the current live attenuated measles vaccine is one of the most successful and cost-effective medical interventions. However, as a result of persisting maternal antibodies and immaturity of the infant immune system, this vaccine is poorly immunogenic in children <9 months old. Immunity against the live vaccine is less robust than natural immunity and protection less durable. There may also be some concern about (vaccine) virus spread during the final stage of an eventual measles… CONTINUE READING